Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1Benjamin Besse, Manuel Cobo, Céline Mascaux et al.|Annals of Oncology|2023Cited by 69
Multi-Arm, Nonrandomized, Open-Label Phase Ib Study to Evaluate Fp1039/Gsk3052230 with Chemotherapy in Nsclc and Mpm with Deregulated Fgf Pathway SignalingPilar Garrido, Ulrik Lassen, Enriqueta Felip et al.|Annals of Oncology|2014Cited by 3